Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0WB8E
|
|||
Former ID |
DIB020778
|
|||
Drug Name |
pyrazolone, 1
|
|||
Synonyms |
compound 43 [PMID:23160941]; compound 43 [PMID:16697190]
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL
|
|||
Formula |
C20H21ClN4O2
|
|||
Canonical SMILES |
CC(C)C1=C(C(=O)N(N1C)C2=CC=CC=C2)NC(=O)NC3=CC=C(C=C3)Cl
|
|||
InChI |
1S/C20H21ClN4O2/c1-13(2)18-17(23-20(27)22-15-11-9-14(21)10-12-15)19(26)25(24(18)3)16-7-5-4-6-8-16/h4-13H,1-3H3,(H2,22,23,27)
|
|||
InChIKey |
PAEBEUZTAPIOIO-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 903895-98-7
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | FMLP-related receptor I (FPR2) | Target Info | Agonist | [2] |
N-formyl peptide receptor (FPR1) | Target Info | Agonist | [1] | |
KEGG Pathway | Rap1 signaling pathway | |||
Neuroactive ligand-receptor interaction | ||||
Staphylococcus aureus infection | ||||
NetPath Pathway | Leptin Signaling Pathway | |||
Panther Pathway | Inflammation mediated by chemokine and cytokine signaling pathway | |||
Pathway Interaction Database | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling | |||
Reactome | G alpha (q) signalling events | |||
G alpha (i) signalling events | ||||
WikiPathways | GPCRs, Class A Rhodopsin-like | |||
Gastrin-CREB signalling pathway via PKC and MAPK | ||||
Peptide GPCRs | ||||
GPCR ligand binding | ||||
GPCR downstream signaling | ||||
Human Complement System |
References | Top | |||
---|---|---|---|---|
REF 1 | Functional characterization of three mouse formyl peptide receptors. Mol Pharmacol. 2013 Feb;83(2):389-98. | |||
REF 2 | Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents. Bioorg Med Chem Lett. 2006 Jul 15;16(14):3713-8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.